These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 8137089)
41. Electroconvulsive therapy in the treatment-resistant patient. Devanand DP; Sackeim HA; Prudic J Psychiatr Clin North Am; 1991 Dec; 14(4):905-23. PubMed ID: 1771153 [TBL] [Abstract][Full Text] [Related]
42. Long-term treatment strategies in major depression: a 2-year prospective naturalistic follow-up after successful electroconvulsive therapy. Martínez-Amorós E; Cardoner N; Soria V; Gálvez V; Menchón JM; Urretavizcaya M J ECT; 2012 Jun; 28(2):92-7. PubMed ID: 22531201 [TBL] [Abstract][Full Text] [Related]
43. [Determinants of relapse after electroconvulsive therapy in depressed patients]. Grüter J; Grözinger M Fortschr Neurol Psychiatr; 2018 Nov; 86(11):711-717. PubMed ID: 30654400 [TBL] [Abstract][Full Text] [Related]
44. Dexamethasone in electroconvulsive therapy: efficacy for depression and post-ECT amnesia. Horne RL; Pettinati HM; Menken M; Sugerman AA; Varga E; Wilson GF Biol Psychiatry; 1984 Jan; 19(1):13-27. PubMed ID: 6704458 [TBL] [Abstract][Full Text] [Related]
45. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression. Eschweiler GW; Vonthein R; Bode R; Huell M; Conca A; Peters O; Mende-Lechler S; Peters J; Klecha D; Prapotnik M; DiPauli J; Wild B; Plewnia C; Bartels M; Schlotter W J Affect Disord; 2007 Aug; 101(1-3):149-57. PubMed ID: 17196664 [TBL] [Abstract][Full Text] [Related]
46. Prolactin release and clinical response to electroconvulsive therapy in depressed geriatric inpatients: a preliminary report. Clark CP; Alexopoulos GS; Kaplan J Convuls Ther; 1995 Mar; 11(1):24-31. PubMed ID: 7796064 [TBL] [Abstract][Full Text] [Related]
47. Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly. Stoudemire A; Hill CD; Morris R; Martino-Saltzman D; Markwalter H; Lewison B Am J Psychiatry; 1991 Oct; 148(10):1336-40. PubMed ID: 1897613 [TBL] [Abstract][Full Text] [Related]
48. Experimental studies of the therapeutic action of electroconvulsive therapy in endogenous depression. The role of the electrical stimulation and of the seizure studied by variation of stimulus intensity and modification by lidocaine of seizure discharge. Cronholm B; Ottosson JO Convuls Ther; 1996 Sep; 12(3):172-94. PubMed ID: 8872406 [TBL] [Abstract][Full Text] [Related]
49. ECT response in depressed patients with and without a DSM-III personality disorder. Zimmerman M; Coryell W; Pfohl B; Corenthal C; Stangl D Am J Psychiatry; 1986 Aug; 143(8):1030-2. PubMed ID: 3728718 [TBL] [Abstract][Full Text] [Related]
50. No early effects of electroconvulsive therapy on tryptophan metabolism and disposition in endogenous depression. Mokhtar AS; Morgan CJ; Bradley DM; Badawy AA Biol Psychiatry; 1997 Aug; 42(3):201-5. PubMed ID: 9232212 [TBL] [Abstract][Full Text] [Related]
51. Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy: data from the Consortium for Research on Electroconvulsive Therapy. Rasmussen KG; Mueller M; Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; O'connor MK; Black JL; Sampson S; Fink M; J ECT; 2006 Jun; 22(2):116-23. PubMed ID: 16801827 [TBL] [Abstract][Full Text] [Related]
52. An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression. Homan S; Lachenbruch PA; Winokur G; Clayton P Psychol Med; 1982 Aug; 12(3):615-24. PubMed ID: 7134319 [TBL] [Abstract][Full Text] [Related]
53. Electroconvulsive therapy use in geriatric depression. Kramer BA J Nerv Ment Dis; 1987 Apr; 175(4):233-5. PubMed ID: 3559535 [TBL] [Abstract][Full Text] [Related]
54. Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study. Rosa MA; Gattaz WF; Pascual-Leone A; Fregni F; Rosa MO; Rumi DO; Myczkowski M; Silva MF; Mansur C; Rigonatti SP; Jacobsen Teixeira M; Marcolin MA Int J Neuropsychopharmacol; 2006 Dec; 9(6):667-76. PubMed ID: 16923322 [TBL] [Abstract][Full Text] [Related]
55. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Segman RH; Shapira B; Gorfine M; Lerer B Psychopharmacology (Berl); 1995 Jun; 119(4):440-8. PubMed ID: 7480524 [TBL] [Abstract][Full Text] [Related]
56. Speed of response to bilateral ECT: an examination of possible predictors in two controlled trials. Shapira B; Lerer B J ECT; 1999 Sep; 15(3):202-6. PubMed ID: 10492858 [TBL] [Abstract][Full Text] [Related]
57. Personality disorder and the outcome of depression: meta-analysis of published studies. Newton-Howes G; Tyrer P; Johnson T Br J Psychiatry; 2006 Jan; 188():13-20. PubMed ID: 16388064 [TBL] [Abstract][Full Text] [Related]
58. Long-term outcome of treatment-resistant depression in older adults. Stoudemire A; Hill CD; Morris R; Lewison BJ Am J Psychiatry; 1993 Oct; 150(10):1539-40. PubMed ID: 8379561 [TBL] [Abstract][Full Text] [Related]
59. What do psychiatrists mean by medication resistance as an indication for electroconvulsive therapy? Husain SS; Kevan IM; Linnell R; Scott AI J ECT; 2005 Dec; 21(4):211-3. PubMed ID: 16301879 [TBL] [Abstract][Full Text] [Related]
60. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]